EcoDrugPlus

Primary Amine Oxidase, Liver Isozyme-Like

Ensembl ID : ENSPCTG00005011608
Gene Symbol: LOC102978430
2 Cross references
220 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSPCTG00005009652
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor

Ensembl ID : ENSPCTG00005021874
Gene Symbol: PTGDR
3 Cross references
118 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSPCTG00005022289
Gene Symbol: PTGDR2
3 Cross references
206 Possible Orthologues:

Prostaglandin E Receptor 1

Ensembl ID : ENSPCTG00005022554
Gene Symbol: PTGER1
3 Cross references
235 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSPCTG00005021953
Gene Symbol: PTGER2
1 Cross references
241 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSPCTG00005020486
Gene Symbol: PTGER3
3 Cross references
194 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSPCTG00005016188
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSPCTG00005015161
Gene Symbol: PTGS1
3 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSPCTG00005003319
Gene Symbol: PTGS2
3 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSPCTG00005014933
Gene Symbol: PSMA7
3 Cross references
155 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSPCTG00005022434
Gene Symbol: PSMA8
3 Cross references
197 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).